FMT

FMT

2337 bookmarks
Custom sorting
Understanding and predicting the efficacy of FMT | Nature Medicine
Understanding and predicting the efficacy of FMT | Nature Medicine
Nature Medicine - Clinical evaluation of FMT is progressing without an adequate understanding of the underlying ecological dynamics; studies are now beginning to fill these gaps, but consensus will...
·nature.com·
Understanding and predicting the efficacy of FMT | Nature Medicine
When microbiomes collide | EMBL
When microbiomes collide | EMBL
Researchers used data from over 300 human faecal microbiota transplants to understand what happens when two gut microbiomes clash.
·embl.org·
When microbiomes collide | EMBL
Coupling microbial metagenomics w/ #MachineLearning enables prediction of strain engraftment after fecal microbiota transplantation for a range of diseases, and may help tailor design of #FMT to achieve clinical outcomes.
Coupling microbial metagenomics w/ #MachineLearning enables prediction of strain engraftment after fecal microbiota transplantation for a range of diseases, and may help tailor design of #FMT to achieve clinical outcomes.
Coupling microbial metagenomics w/ #MachineLearning enables prediction of strain engraftment after fecal microbiota transplantation for a range of diseases, and may help tailor design of #FMT to achieve clinical outcomes.https://t.co/5395DZcnIf— Nature Medicine (@NatureMedicine) September 16, 2022
·twitter.com·
Coupling microbial metagenomics w/ #MachineLearning enables prediction of strain engraftment after fecal microbiota transplantation for a range of diseases, and may help tailor design of #FMT to achieve clinical outcomes.
Kira Newman, MD, PhD on Twitter
Kira Newman, MD, PhD on Twitter
Lots of interesting findings here. -combo of administration modes ⬆️ engraftment-engraftment is phylum and species dependent~more engraftment assoc’d with more clinical success#FMT #Cdiff-ML may be able to help pick donors for individual recipients https://t.co/WpW34i0jMJ— Kira Newman, MD, PhD (@KiraNewmanMDPhD) September 15, 2022
·twitter.com·
Kira Newman, MD, PhD on Twitter
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Fecal microbiota transplantation (FMT) is highly effective against recurrent Clostridioides difficile infection and is considered a promising treatment for other microbiome-related disorders, but a comprehensive understanding of microbial engraftment dynamics is lacking, which prevents informed appl …
·pubmed.ncbi.nlm.nih.gov·
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases
Higher levels of microbiota engraftment linked to greater chances of transplantation success - News-Medical.Net
Higher levels of microbiota engraftment linked to greater chances of transplantation success - News-Medical.Net
From incurable intestinal infections to metabolic syndrome, from melanoma, to chronic inflammatory bowel disease, such as irritable bowel syndrome, to Tourette's syndrome: many diseases can potentially be cured by Fecal Microbiota Transplantation (FMT), and researchers from the Catholic University, Rome and the University of Trento have shown that the greater the level of engraftment of the transplanted microorganisms, the greater the chances of success of the therapy.
·news-medical.net·
Higher levels of microbiota engraftment linked to greater chances of transplantation success - News-Medical.Net
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel - The Lancet Gastroenterology & Hepatology
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel - The Lancet Gastroenterology & Hepatology
Faecal microbiota transplantation (FMT) is an established treatment for recurrent Clostridioides difficile infection, recommended by several guidelines for this indication.1,2 FMT is not only more effective than antibiotics for recurrent C difficile infection,3 but also able to prevent C difficile infection-related complications.4 Several actions have been taken to guarantee and expand FMT availability, and to increase its safety. Stool banks are a model that ensures a high level of product quality and reliability of supply.
·thelancet.com·
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel - The Lancet Gastroenterology & Hepatology
@simone_s_li had previously shown in 2016 that donor and recipient strain populations can coexist for a long time post #FMT – and that the resolution of individual microbial SNVs is necessary to trace this. 2/9
@simone_s_li had previously shown in 2016 that donor and recipient strain populations can coexist for a long time post #FMT – and that the resolution of individual microbial SNVs is necessary to trace this. 2/9
@simone_s_li had previously shown in 2016 that donor and recipient strain populations can coexist for a long time post #FMT – and that the resolution of individual microbial SNVs is necessary to trace this. 2/9 https://t.co/SqifQTw2yv— Bork Group at EMBL Heidelberg (@BorkLab) September 15, 2022
·twitter.com·
@simone_s_li had previously shown in 2016 that donor and recipient strain populations can coexist for a long time post #FMT – and that the resolution of individual microbial SNVs is necessary to trace this. 2/9
Can we predict what happens to the microbiome following an #FMT? @TSBSchm @simone_s_li conducted a metagenomic metastudy (out today @NatureMedicine) to look into this in detail. TL;DR: it's complicated. 1/9
Can we predict what happens to the microbiome following an #FMT? @TSBSchm @simone_s_li conducted a metagenomic metastudy (out today @NatureMedicine) to look into this in detail. TL;DR: it's complicated. 1/9
Can we predict what happens to the microbiome following an #FMT? @TSBSchm @simone_s_li conducted a metagenomic metastudy (out today @NatureMedicine) to look into this in detail. TL;DR: it's complicated. 1/9 https://t.co/5lwYyy8CtT— Bork Group at EMBL Heidelberg (@BorkLab) September 15, 2022
·twitter.com·
Can we predict what happens to the microbiome following an #FMT? @TSBSchm @simone_s_li conducted a metagenomic metastudy (out today @NatureMedicine) to look into this in detail. TL;DR: it's complicated. 1/9
We started from the realisation that diff smaller studies on #FMT had come to v diff conclusions on microbiome dynamics. So we collected public and newly generated data from 316 FMTs across different indications and conducted a metagenomic meta-study. 2/
We started from the realisation that diff smaller studies on #FMT had come to v diff conclusions on microbiome dynamics. So we collected public and newly generated data from 316 FMTs across different indications and conducted a metagenomic meta-study. 2/
We started from the realisation that diff smaller studies on #FMT had come to v diff conclusions on microbiome dynamics. So we collected public and newly generated data from 316 FMTs across different indications and conducted a metagenomic meta-study.2/ pic.twitter.com/f1WlVW6jd4— Sebastian Schmidt (@TSBSchm) September 15, 2022
·twitter.com·
We started from the realisation that diff smaller studies on #FMT had come to v diff conclusions on microbiome dynamics. So we collected public and newly generated data from 316 FMTs across different indications and conducted a metagenomic meta-study. 2/
Fecal philanthropist donates poop to save lives - CBC.ca
Fecal philanthropist donates poop to save lives - CBC.ca
Healthcare professionals have put out an open call for poop donors at St. Joseph's Health Care London, where fecal transplants have become a routine procedure used to treat potentially life-threatening C. difficile, a cause of antibiotic-associated diarrhea.
·cbc.ca·
Fecal philanthropist donates poop to save lives - CBC.ca
FMT and male infertility: A new potential treatment?
FMT and male infertility: A new potential treatment?
One factor that is known to decrease sperm quality is obesity, so a recent paper looked into the effects of a high-fat diet (HFD) on sperm motility [1]. A HFD causes microbial dysbiosis of the gut, leading to a disruption in the gut microbiome [1].
·dwscientific.com·
FMT and male infertility: A new potential treatment?
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience
Clostridioides difficile (Clostridium difficile in older taxonomy) is a gram-positive anaerobic and bacteria enabled by endospores. Clostridioides difficile is currently the main cause of nosocomial infections in developed countries. Due to the high probability of developing bacterial resistance to …
·pubmed.ncbi.nlm.nih.gov·
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience
Ben Mullish on Twitter
Ben Mullish on Twitter
Great to represent @IHepatology @ImperialMDR at the international #FMT conference in Copenhagen - thanks to @ChristianHvas, @SMDBaunwall and colleagues for organising a very interesting event @BugsImperial https://t.co/OAaWKEhAwG pic.twitter.com/SyqWxOhp2T— Ben Mullish (@bhmullish) September 13, 2022
·twitter.com·
Ben Mullish on Twitter
@tariqraseen from @MayoClinicGIHep presenting an updated meta-analysis on efficacy of #FMT treatment for #Cdiff at the FMT conference in @VisitCopenhagen by @UCPH_Research and @novonordiskfond
@tariqraseen from @MayoClinicGIHep presenting an updated meta-analysis on efficacy of #FMT treatment for #Cdiff at the FMT conference in @VisitCopenhagen by @UCPH_Research and @novonordiskfond
@tariqraseen from @MayoClinicGIHep presenting an updated meta-analysis on efficacy of #FMT treatment for #Cdiff at the FMT conference in @VisitCopenhagen by @UCPH_Research and @novonordiskfond pic.twitter.com/Sbgv5WWeH6— Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) (@Khanna_S) September 13, 2022
·twitter.com·
@tariqraseen from @MayoClinicGIHep presenting an updated meta-analysis on efficacy of #FMT treatment for #Cdiff at the FMT conference in @VisitCopenhagen by @UCPH_Research and @novonordiskfond
Cells | Free Full-Text | A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection | HTML
Cells | Free Full-Text | A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection | HTML
Fecal microbiota transplantation (FMT) is highly effective in recurrent Clostridioides difficile infection (CDI); increasing evidence supports FMT in severe or fulminant Clostridioides difficile infection (SFCDI). However, the multifactorial mechanisms that underpin the efficacy of FMT are not fully understood. Systems biology approaches using high-throughput technologies may help with mechanistic dissection of host-microbial interactions. Here, we have undertaken a deep phenomics study on four adults receiving sequential FMT for SFCDI, in which we performed a longitudinal, integrative analysis of multiple host factors and intestinal microbiome changes. Stool samples were profiled for changes in gut microbiota and metabolites and blood samples for alterations in targeted epigenomic, metabonomic, glycomic, immune proteomic, immunophenotyping, immune functional assays, and T-cell receptor (TCR) repertoires, respectively. We characterised temporal trajectories in gut microbial and host immunometabolic data sets in three responders and one non-responder to sequential FMT. A total of 562 features were used for analysis, of which 78 features were identified, which differed between the responders and the non-responder. The observed dynamic phenotypic changes may potentially suggest immunosenescent signals in the non-responder and may help to underpin the mechanisms accompanying successful FMT, although our study is limited by a small sample size and significant heterogeneity in patient baseline characteristics. Our multi-omics integrative longitudinal analytical approach extends the knowledge regarding mechanisms of efficacy of FMT and highlights preliminary novel signatures, which should be validated in larger studies.
·mdpi.com·
Cells | Free Full-Text | A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection | HTML
Cells | Free Full-Text | Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Cells | Free Full-Text | Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
Numerous studies show a modification of the gut microbiota in patients with obesity or diabetes. Animal studies have also shown a causal role of gut microbiota in liver metabolic disorders including steatosis whereas the human situation is less clear. Patients with metabolic dysfunction associated fatty liver disease (MAFLD) also have a modification in their gut microbiota composition but the changes are not fully characterized. The absence of consensus on a precise signature is probably due to disease heterogeneity, possible concomitant medications and different selection or evaluation criteria. The most consistent changes were increased relative abundance of Proteobacteria, Enterobacteriaceae and Escherichia species and decreased abundance of Coprococcus and Eubacterium. Possible mechanisms linking the microbiota and MAFLD are increased intestinal permeability with translocation of microbial products into the portal circulation, but also changes in the bile acids and production of microbial metabolites such as ethanol, short chain fatty acids and amino acid derivatives able to modulate liver metabolism and inflammation. Several interventional studies exist that attempt to modulate liver disease by administering antibiotics, probiotics, prebiotics, synbiotics, postbiotics or fecal transplantation. In conclusion, there are both gaps and hopes concerning the interest of gut microbiome evaluation for diagnosis purposes of MAFLD and for new therapeutic developments that are often tested on small size cohorts.
·mdpi.com·
Cells | Free Full-Text | Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time?
💊Microbiome restoration key to manage recurrent CDI ✅Approved microbiome therapies likely to replace traditional FMT @Khanna_S at #FMT conference @novonordiskfond @VisitCopenhagen
💊Microbiome restoration key to manage recurrent CDI ✅Approved microbiome therapies likely to replace traditional FMT @Khanna_S at #FMT conference @novonordiskfond @VisitCopenhagen
💊Microbiome restoration key to manage recurrent CDI✅Approved microbiome therapies likely to replace traditional FMT@Khanna_S at #FMT conference @novonordiskfond @VisitCopenhagen pic.twitter.com/fTTsXzsuhS— Raseen Tariq, MBBS (@tariqraseen) September 12, 2022
·twitter.com·
💊Microbiome restoration key to manage recurrent CDI ✅Approved microbiome therapies likely to replace traditional FMT @Khanna_S at #FMT conference @novonordiskfond @VisitCopenhagen
Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) on Twitter
Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) on Twitter
@h_sokol: Excellent talk on the role of microbes and #FMT in #IBD➡️Microbes are involved in the pathogenesis➡️Need to target microbes but also immune system in addition @novonordiskfond @UCPH_Research pic.twitter.com/OOQ3DQPgoB— Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) (@Khanna_S) September 12, 2022
·twitter.com·
Sahil Khanna, MBBS, MS, FACG, AGAF (he/him) on Twitter
Simon MD Baunwall on Twitter
Simon MD Baunwall on Twitter
Opening of the long-awaited FMT conference in Copenhagen. 150+ FMT interested people!#FMT #Microbiota pic.twitter.com/rJGakxESyq— Simon MD Baunwall (@SMDBaunwall) September 12, 2022
·twitter.com·
Simon MD Baunwall on Twitter
Cells | Free Full-Text | Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
Cells | Free Full-Text | Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
Faecal microbiota transplantation (FMT) is the recommended treatment for recurrent C. difficile infection (rCDI) following a second recurrence. FMT is considered safe in the short term when procedures for the screening of donors and transferred material are followed. However, the long-term safety profile of FMT treatment is largely unknown. In a retrospective cohort study, we assessed the long-term safety of patients treated for rCDI with FMT or a fixed bacterial mixture, rectal bacteriotherapy (RBT). The overall survival, risk of hospital admission, onset of certain pre-specified diseases (cancer, diabetes mellitus, hypertension and inflammatory bowel disease) and risk of being diagnosed with a multidrug-resistant organism were assessed by undertaking a review of the treated patients’ medical records for up to five years following treatment. A total of 280 patients were treated for rCDI with FMT (n = 145) or RBT (n = 135) between 2016 and 2020. In the five years following treatment, there were no differences in survival (adjusted hazard ratio (aHR) 1.03; 95% CI 0.68–1.56), p = 0.89), risk of hospital admission ((aHR 0.92; 95% CI 0.72–1.18), p = 0.5) or onset of any of the analysed diseases. In conclusion, FMT was not associated with increased mortality, risk of hospital admission or onset of disease following treatment when compared with RBT.
·mdpi.com·
Cells | Free Full-Text | Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
Adelaide IBD Group on Twitter
Adelaide IBD Group on Twitter
Faecal microbiota transplantation as a treatment for functional GI disorders- are we there yet? #AGW2022 #microbiome #FMT @bresch23 pic.twitter.com/FytukyF8AX— Adelaide IBD Group (@ADL_IBD) September 11, 2022
·twitter.com·
Adelaide IBD Group on Twitter
GutMicrobiota Health on Twitter
GutMicrobiota Health on Twitter
Nice weekend reading: summary of selected prebiotic, probiotic, and microbiome data presented at the International Scientific Conference of Probiotics, Prebiotics, Gut Microbiota and Health via @EMJReviews https://t.co/iOLzeAk4r8 pic.twitter.com/QGfHgMhERy— GutMicrobiota Health (@GMFHx) September 9, 2022
·twitter.com·
GutMicrobiota Health on Twitter